[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Anna Erenbourg\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100492909","automated-fetal-cardiac-function-in-babies-affected-by-heart-diseases-100492909",false,"NCT05698277","Automated Fetal Cardiac Function in Babies Affected by Heart Diseases","Automated Fetal Cardiac Function Parameters in Congenital Heart Disease","Inclusion Criteria:\n\n* Inclusion criteria for the CHD Group are as follows: singleton pregnancies; gestational age between 19+6 and 36+6 weeks gestation, determined by the last menstrual period and confirmed by first trimester ultrasound; isolated congenital cardiac anomaly diagnosed.\n* Inclusion criteria for the Control Group are as follows: singleton pregnancies; gestational age between 19+6 and 27+6 weeks gestation, determined by the last menstrual period and confirmed by first trimester ultrasound; no congenital cardiac anomaly diagnosed\n\nExclusion Criteria common to the 2 groups (Cases and Controls):\n\n* Fetuses whose mothers have comorbidities that have been proven to potentially affect cardiac function including:\n\n  * intrahepatic cholestasis\n  * pre-gestational and gestational diabetes\n  * preeclampsia\n  * growth restricted fetuses defined as estimated fetal weight or abdominal circumference \\\u003C3rd percentile for GA\n* Fetuses with other structural extracardiac anomalies at ultrasound examination\n* Fetuses affected by any diagnosed genetic abnormalities",true,"FEMALE","18 Years",{"count":20,"type":21},495,"ESTIMATED","OBSERVATIONAL","The goal of this international multicentre prospective observational cohort study with a nested case-control study is to test some automated fetal heart functional parameters in healthy babies compared to those affected by a congenital heart condition.\n\nThe main questions it aims to answer are:\n\n* If there is a significant difference between the two populations of infants\n* Whether these parameters could significantly improve the predictive value of actual cardiovascular profile score to predict hydrops Participants will be offered two automated cardiac function assessments between 27+6 and 29+6 gestational weeks and between 34+6 and 36+6 weeks of gestation. Functional parameters will be compared between the two study groups and evaluated over time.",[25,26],"Congenital Heart Defect","Cardiac Function",[28,29],"Congenital Heart Diseases","Fetal Cardiac Function","RECRUITING","2024-12-09",{"date":33,"type":34},"2024-12-10","ACTUAL",{"date":36,"type":34},"2023-05-01",{"date":38,"type":21},"2028-02-01",{"name":40,"class":41},"Anna Erenbourg","OTHER",7,""]